Production and use of antibodies against synthetic peptides.
about
Bcipep: a database of B-cell epitopes.The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A proteinHuman DNA polymerase alpha catalytic polypeptide binds ConA and RCA and contains a specific labile site in the N-terminusIdentification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirusMolecular cloning and sequence of cDNA encoding polyoma medium tumor antigen-associated 61-kDa proteinIslet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigenAdvances in Fmoc solid-phase peptide synthesisStructural and Computational Biology in the Design of Immunogenic Vaccine AntigensComputational prediction of conformational B-cell epitopes from antigen primary structures by ensemble learning.Evolutionary expression of the neuronal form of the src protein in the brain.The recognition of proteins and peptides by antibodies.Prediction of conformational B-cell epitopes from 3D structures by random forests with a distance-based feature.Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.Recent advances in B-cell epitope prediction methodsPredicting flexible length linear B-cell epitopes.Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles.Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame.Predicting linear B-cell epitopes using string kernelsPeptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides.Carbohydrates as antigenic determinants of glycoproteinsProduction of polyclonal antibodies to feline tumor necrosis factor.Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cellsA synthetic peptide corresponding to the cleavage region of VP3 from rotavirus SA11 induces neutralizing antibodies.Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.Structure and expression of the gene coding for the alpha-subunit of DNA-dependent RNA polymerase from the chloroplast genome of Zea mays.Topology of the 32-kd liver gap junction protein determined by site-directed antibody localizations.Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists.Diversity of matrix protein in subacute sclerosing panencephalitis and measles virus-infected cells.T-cell recognition of measles virus haemagglutinin studied in a mouse model.Global substrate specificity profiling of post-translational modifying enzymes.The use of databases, data mining and immunoinformatics in vaccinology: where are we?In Silico Prediction of Linear B-Cell Epitopes on Proteins.Response of guinea pigs to the synthetic peptide-M of the uveitogenic, retinal S-antigen: antisera immunofluorescent reactivity on normal guinea pig retina.Detection of cells producing murine interferon-α using antipeptide antibodiesProduction of an epitope-specific antibody using recombinant repetitive oligonucleotides
P2860
Q21266599-82AB92E0-C0C4-4CAB-B916-5D6794445EA3Q24307350-01942836-9BA6-4E76-9ED4-8C35109B59DEQ24308171-C2548242-83BB-47A2-AC83-FC57A0530C58Q24337360-FF93D9B1-FC60-427F-8646-4DAFEA585672Q24603540-428F4572-E79E-4B34-82CB-62C49300E2CEQ24613961-29052304-3F29-4B4E-8CEE-60AFB6D4A3F7Q26770921-CB078960-0C4B-4AFB-B945-D3B9AD910659Q26777382-2869DF80-C5F6-4368-82E7-66BEF58558EEQ31087675-32153B21-5931-467B-8145-C643E673EABAQ33864455-1E46D9D2-FC55-440D-80D0-5ED8E6645D69Q33993576-BC4A4F4C-FF26-4487-A73B-F38E69CC3A4AQ33994173-1C0D23EE-AB45-4CD2-98E4-27FF16B28D32Q34225659-843A0D9C-23F2-44D0-8358-37B68975F5D3Q34312506-27772CC2-2151-44B4-A5C0-55EB7D24A217Q36105058-1A281022-6A20-4FF3-AA0B-9133A699C77BQ36796177-5B6F1EA2-EEBD-492C-AB4D-478E7B05DBACQ36865623-E817CAD7-4EC3-4CE7-B31A-99F719E2E698Q37196733-2A28C609-44A2-4DD9-B6B0-8066FAB5E52AQ38123488-F3BA8BD5-799C-47A2-BDE3-5504057E5D66Q38179958-59204459-9F62-4231-A9C6-DEA9C4D134A3Q39811350-941D21F1-2668-4714-9046-4ACAE21D20DFQ40021232-0E120D21-9768-4C76-8817-450B7EBAA90BQ40130945-8173F3F9-3EF1-41BA-B0AD-E5DA39EE98F2Q40433315-7CF595C1-F900-4AC5-9F3B-50467333D5A7Q40547270-21CD33D7-ED7D-4359-AB99-D50032EDA509Q41092749-9A12FACC-F9E9-4D92-8B32-61C86D69ADDFQ41448265-339846F0-36A0-4E7B-82E0-F695C5139ACEQ44245377-EC5B397D-2F9F-45BA-B1A3-D55E99A074C1Q45843005-381A7200-7877-4BD8-A949-146DEB3639DAQ46327888-560E6B84-6DDA-4688-87D7-2EDE78562D19Q47262746-E59732BA-2479-4684-9AD0-F2CE4BBB0C7CQ51359804-848E42B3-DDEC-44F0-874C-A1386A2344E0Q53873458-3C8F0773-ED90-4814-9BE4-9629B4B488A1Q57272401-8AC0E30A-9503-40C2-83F7-F5462FDCE1A4Q58190548-60496FA6-0619-4E55-99DD-8A9E754061D9
P2860
Production and use of antibodies against synthetic peptides.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Production and use of antibodies against synthetic peptides.
@en
type
label
Production and use of antibodies against synthetic peptides.
@en
prefLabel
Production and use of antibodies against synthetic peptides.
@en
P1476
Production and use of antibodies against synthetic peptides.
@en
P2093
P304
P356
10.1016/0022-1759(86)90001-3
P577
1986-04-01T00:00:00Z